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ABSTRACT Safe and effective contraceptive agents are needed to manage overabundant populations of
cervids in settings where traditional management methods such as hunting are prohibited or impractical. We
used GonaConTM Immunocontraceptive Vaccine to reduce reproduction in individual white-tailed deer
(Odocoileus virginianus) on a fully fenced corporate-office campus in suburban New Jersey, USA. In July–
August 2005, we captured, marked, injected, and released 47 adult females and then monitored their
reproductive performance for 2 years. Thirty-two of these females each received a 1.0-mL injection of
GonaCon vaccine, and 15 control females were given sham injections. Field observations of udder condition
during summers of 2006 and 2007 were used to determine which adult female deer were lactating; lactation
was used as an indicator of imminent or recent parturition. During summer 2006, 8 of 24 GonaCon-treated
deer were pregnant, in contrast to 12 of 13 control deer. During summer 2007, 2 years after injections were
given, 13 of 23 GonaCon-treated and 10 of 12 control animals were pregnant. We also captured, vaccinated,
and released fawns (both sexes) and yearling and adult males and then monitored their reproductive status.
Immunocontraception of fawns was unsuccessful. In some GonaCon-treated males (all age classes), serum
testosterone concentrations and development of testes and antlers were reduced. Higher anti-gonadotropin-
releasing-hormone antibody titers were associated with greater infertility in females and with lower values for
reproductive parameters in males. GonaCon reduced reproduction in wild adult female white-tailed deer, but
greater contraceptive efficacy may be required for it to gain widespread acceptance and use by natural resource
managers.  2011 The Wildlife Society.
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Local populations of white-tailed deer (Odocoileus virgin-
ianus) have become overabundant in many regions of North
America, where they are causing problems for residents and
natural resource managers (Creˆte and Daigle 1999). Deer–
motor-vehicle collisions (Etter et al. 2000), severe over-
browsing of native and ornamental vegetation (Rooney
and Waller 2003), and adverse effects on local avian com-
munities (McShea and Rappole 2000) are among the prob-
lems caused by overabundant deer. Hunting is prohibited in
many urban, suburban, and public park settings, and other
deer management tools must be used. Contraception and
other nonlethal deer management approaches are increas-
ingly preferred by many urban and suburban residents (Stout
et al. 1997, Lauber and Knuth 2000). Immunocontraception
offers natural resource managers another tool to reduce
reproduction in overabundant wildlife populations
(Fagerstone et al. 2002).
Although efforts to develop safe and effective wildlife
contraceptive agents have been underway for about 50 years
(Davis 1961, Vandenbergh and Davis 1962, Balser 1964),
only 2 contraceptive products have been registered in the
United States for wildlife: GonaConTM Immunocontraceptive
Vaccine (National Wildlife Research Center, Fort Collins,
CO) for adult female white-tailed deer, and a nicarbazin-
based contraceptive bait (‘‘OvoControl’’) for Canada Geese
(Branta canadensis), certain domestic ducks, and pigeons
(Columba livia; Innolytics, Rancho Santa Fe, CA).
Among the obstacles to the development and registration
of wildlife contraceptives is the achievement of objectives
related to safety, efficacy, practicality, and humaneness of
treatment. To be registered by the United States
Environmental Protection Agency (EPA) and to gain wide-
spread acceptance among wildlife management professionals,
a contraceptive agent must: 1) not adversely affect the
health, social behavior, or population structure of the target
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species; 2) not adversely affect nontarget species; 3) provide a
complete, long-lasting (but ideally, reversible) contraceptive
effect; 4) be cost-effective; and 5) not cause treated food
animals to become unfit for human consumption (Fagerstone
et al. 2010).
GonaCon Immunocontraceptive Vaccine is a gonadotro-
pin-releasing hormone (GnRH)-based wildlife contracep-
tive agent that has safely induced temporary infertility in
many mammalian species (see refs in Gionfriddo et al. 2011).
One intramuscular injection of GonaCon suppresses mam-
malian reproduction (M or F) for multiple years (Miller
et al. 2004). GonaCon was registered with the United
States EPA in September 2009 as a restricted-use product
for the contraception of adult, female, white-tailed deer via
hand injection (Fagerstone et al. 2010). Regarding potential
risk associated with consuming deer treated with GonaCon
vaccine, the EPA (Farwell 2009:2) has stated ‘‘There is little
likelihood of exposure to hormonally active compound from
deer meat because GnRH is a protein that is digested and not
absorbed intact. Like other proteins, GnRH is too large and
polar to pass through the membranes of the gastrointestinal
tract. Proteins are digested into their component amino acids
in the stomach and small intestines.’’
We tested GonaCon’s contraceptive efficacy in white-
tailed deer adults and fawns of both sexes. Adult females
were the primary focus of the study because they will be the
targets of real-world applications of GonaCon vaccine by
natural resource managers. Fawns were tested to determine
whether their immune systems were sufficiently mature to
mount and maintain the strong immune responses to vacci-
nation that are required to achieve and sustain a contracep-
tive effect. We also tested GonaCon in yearling and adult
males. Although GonaCon is not registered or recom-
mended for use in male deer (Killian et al. 2005, Curtis
et al. 2008), deer-management field activities in North
America often occur during winter when ambient temper-
atures are lower, deer are more visible (due to reduced
vegetative cover), and deer occur in larger groups than at
other times of year. Male deer lack antlers during late winter
and can be mistaken for females. We vaccinated males to
determine the effects of GonaCon treatment on male deer
that might inadvertently be treated during winter manage-
ment programs (if a GnRH vaccine is registered for remote
injection or oral delivery in bait).
The objective of this 2-year field study was to evaluate the
efficacy of GonaCon Immunocontraceptive Vaccine in in-
dividual wild white-tailed deer by determining the propor-
tion of treated individuals that became infertile and the
duration of induced infertility. For each year, we tested
the hypothesis that pregnancy rates of adult females did
not differ between GonaCon-treated and control deer.
For male deer, we tested hypotheses to determine whether
serum testosterone concentrations or testicular circumfer-
ences differed among treatment groups or age classes.
This research differs from our previous studies of GonaCon
immunocontraception of white-tailed deer in several ways.
Most studies involved captive deer at Pennsylvania State
University where optimal diets and veterinary care (including
de-worming) were routinely provided. In contrast, our field
studies in Maryland, USA (Gionfriddo et al. 2009) and New
Jersey, USA (Gionfriddo et al. 2011) involved wild deer
subpopulations that lived independently of humans and
ranged freely on very large, fenced, partially forested sites
where forage was extremely overbrowsed, deer were exposed
to natural environmental conditions, and deer received no
veterinary care. Important differences between the Maryland
and New Jersey field studies included the occupation of a
single site by all study deer in New Jersey (GonaCon-treated
and control deer occupied adjacent but different fenced sites
in Maryland, for political and logistical reasons) and the
injection of New Jersey control females with a sham material
(controls in Maryland were not injected, again for political
and logistical reasons). In addition, only adult female deer
were tested in the Maryland study.
STUDY AREA
The study was conducted on a 123-ha corporate office
campus near Madison, New Jersey, USA. Vegetation on
the site consisted of hardwood forest (about 20%), old fields
in various stages of secondary succession (about 20%), lawns
(about 40%), and landscaping near buildings. A 2.4-m-tall
chain-link fence surrounded the property. Although the site
was bounded by public roads on all 4 sides, public access to
the campus was prohibited, and security gates and guards
controlled access of authorized personnel. Despite the pres-
ence of the fence, a few deer entered or left the study area by
running through gates opened briefly by guards for vehicular
traffic. Most of the study area was accessible via a network of
paved and gravel roads that was used during deer capture and
observation activities. Limited food availability in forested
areas caused deer to forage heavily on lawn areas where they
were easily observed with binoculars and spotting telescopes.
Long-term patterns of temperature and precipitation for
the study area are summarized elsewhere (Gionfriddo
et al. 2011).
METHODS
Capture and Treatments
General.—We captured deer at night with tranquilizer
darts and fitted each animal with numbered ear tags and a
radiotelemetry collar before reversing anesthesia and releas-
ing deer at their capture sites, as described by Gionfriddo
et al. (2011). We gave each deer a 1.0-mL injection by hand
to the deep musculature of the upper hind limb (see below); if
a deer had been darted in a hind limb, we delivered the hand
injection to the opposite hind limb. We observed all study
deer during the summer(s) between their capture and
October 2007, when deer were collected and necropsied.
Adult females.—During July and early August 2005, we
captured all adult females (n ¼ 47) present on the study area.
We injected each female with GonaCon Immunocontraceptive
Vaccine (n ¼ 32; each 1.0-mL dose of GonaCon contained
1,000 mg of conjugated GnRH-hemocyanin in a water-in-
oil emulsion) or with a shammaterial (n ¼ 15) that consisted
of AdjuVacTM adjuvant (National Wildlife Research
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Center) and mollusk stabilizing buffer (i.e., GonaCon vac-
cine without GnRH and without mollusk hemocyanin,
which usually serves as a carrier molecule for the GnRH).
We collected a blood sample from the jugular or femoral vein
of each female for measurement of pretreatment serum anti-
GnRH antibody titers. Four GonaCon-treated adult females
that became pregnant during autumn 2005 were recaptured
in October 2006 and given a second vaccine injection to
determine the effects of a booster dose on contraceptive
efficacy. We assumed that these 4 females would (without
boosting) have become pregnant during autumn 2006, and
we classified them as pregnant for the 2007 efficacy analysis.
Four other GonaCon-treated females were recaptured and
reinjected with GonaCon in June 2007, after their repro-
ductive status for spring 2007 had already been determined
through observations of udder condition (1 of 4 had lactated
in 2007; status was confirmed at necropsy).
Fawns and males.—To investigate the effects of GonaCon
vaccination on young deer treated during their first winter,
we captured, vaccinated, and released 8-month-old female
fawns (n ¼ 4) in February 2006. To determine whether
GonaCon would elicit strong enough immune responses
to induce infertility in 3–4-month-old fawns, and to estab-
lish the duration of such responses via evaluation of antibody
titers, we captured fawns (8 F and 8 M) during September–
October 2006, vaccinated them with GonaCon, and released
them. We captured, vaccinated, and released yearling
(n ¼ 3) and adult (n ¼ 7) males during March 2007 to
investigate the effects of wintertime vaccination with
GonaCon on antibody and testosterone levels, testis size,
and antler development in male white-tailed deer. Finally, to
provide baseline data on untreated males, we collected pre-
viously uncaptured males (4 yearlings and 9 ad) during
October 2007 for necropsy evaluation.
Evaluation of Contraceptive Efficacy
We evaluated the contraceptive efficacy of GonaCon vaccine
in experimental female deer during 2006 and 2007 by using
spring and summer field observations of udder condition in
vaccinated and control deer to identify animals that were
lactating. Lactation was used as an indicator of imminent
parturition (i.e., current pregnancy) or recent pregnancy
(Whitten 1995, Pojar and Bowden 2004, Gionfriddo
et al. 2009). By repeatedly observing the udders of deer
throughout the fawn-bearing and fawn-rearing seasons in
2006 and 2007, we were able to determine which individuals
became pregnant, although we were unable to tell how many
fawns were born to each female, or whether the fawn(s)
survived. We used 1-tailed Fisher’s exact tests (a ¼ 0.05,
1 df) to compare, for each year, the proportion of GonaCon-
treated females that lactated with the proportion of control
females that lactated. The experimental unit was the indi-
vidual deer.
Serum concentrations of anti-GnRH antibodies also can be
used to assess immunocontraceptive efficacy (Miller et al.
2000). We used enzyme-linked immunosorbent assays
(ELISAs) to measure serum antibody titers (Muller et al.
1997) in blood collected from vaccinated and control deer of
both sexes at the conclusion of field activities in October
2007.We collected blood samples by cardiac puncture within
1 min of death after deer were shot in the head or neck with a
high-powered rifle as they rested or foraged (no chase). We
stored blood samples in a cooler or refrigerator until we
isolated serum by centrifugation and shipped it to the
National Wildlife Research Center in Fort Collins,
Colorado, USA for analysis. An experienced wildlife veteri-
narian conducted field necropsies by following standard
procedures described by Munson (2010). Examination of
reproductive tracts during necropsy provided additional in-
formation on the reproductive status of study deer.
We investigated GonaCon’s effects on reproductive status
in male deer through necropsy observations and evaluation of
blood serum in GonaCon-treated and noninjected control
males. At necropsy in October 2007, we measured testicular
circumferences to the nearest 0.5 cm and characterized the
development of antlers (e.g., ‘‘buttons,’’ ‘‘spikes,’’ ‘‘2  2’’).
Later, we evaluated serum anti-GnRH antibody levels and
testosterone concentrations via ELISAs. We then used 1-
tailed, 2-sample t-tests (a ¼ 0.05) to compare mean testos-
terone levels and testicular circumferences of vaccinated and
control males. All aspects of this research were approved by
the Institutional Animal Care and Use Committee of the
National Wildlife Research Center.
RESULTS
Adult Females
By June 2006, 8 of 32 GonaCon-treated and 2 of 15 control
females had died or left the study site (Table 1). Field
evaluations of udder condition were conducted during the
summers of 2006 and 2007 by 2 independent observers.
Because their conclusions were 100% in agreement when
the same deer was studied (n ¼ 55), the findings were
considered conclusive when only one observer was able to
Table 1. Reproductive status of GonaCon-treated and control adult, female, white-tailed deer in New Jersey, USA, 2006–2007.
Treatment group n (2005) n (2006)a Pregnant (2006) Not pregnant (2006) n (2007)b Pregnant (2007) Not pregnant (2007)
GonaCon 32 24 8 (33%)c 16 (67%) 23 13 (57%)d 10 (43%)
Control 15 13 12 (92%)c 1 (8%) 12 10 (83%)d 2 (17%)
a By Jun 2006, 8 GonaCon-treated and 2 control deer were no longer on the study area. Three deer (2 GonaCon-treated and 1 control) had been killed by
collisions with motor vehicles, and 5 (4 treated and 1 control) deer had died of unknown causes. In addition, 2 treated deer had apparently left the study area.
b By Jun 2007, 2 additional deer (1 treated and 1 control) had died of unknown causes. The treated deer that died was 1 of the 2 treated deer (mentioned above)
that had left the study area before summer 2006. The other treated deer that had left the study area could not be located in 2007. All 8 deer given booster
vaccinations in Oct 2006 and Jun 2007 were included in the 2007 analysis (5 were pregnant).
c Rates of pregnancy were higher in control F than in GonaCon-treated F during 2006 (Fisher’s exact test, P < 0.001).
d Rates of pregnancy were not higher in control F than in GonaCon-treated F during 2007 (Fisher’s exact test, P ¼ 0.112).
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study a deer (n ¼ 14). During summer 2006, 8 (33%) of the
24 remaining vaccinated females and 12 (92%) of the 13
control females lactated (Table 1). The pregnancy rate
among control deer was nearly 3 times that of GonaCon-
treated deer (Fisher’s exact test, P < 0.001).
During summer 2007, 13 (57%) of 23 GonaCon-treated
females and 10 (83%) of 12 control females lactated
(Table 1). Necropsy observations in October 2007 confirmed
the lactational status of these deer, except female number 14,
who had stopped lactating by October. Although the preg-
nancy rate among control deer during 2007 was more than
45% higher than that of GonaCon-treated deer, the differ-
ence was not significant (Fisher’s exact test, P ¼ 0.112).
Anti-GnRH antibody titers ranged from 0 (n ¼ 2) to
1:128,000 (n ¼ 5) in GonaCon-treated adult females 2 years
after treatment. Fifteen (83%) of the 18 vaccinated adult
female deer we evaluated had titers 1:16,000, including
3 females that were given booster injections during the field
study (deer no. 17 and 29 in Oct 2006, and deer no. 16 in Jun
2007, all of which had antibody titers of 1:128,000). All
12 control females had titers of 0.
Both ovaries were small and inactive in 8 (31%) of 26 adult
deer at necropsy in October 2007; 7 of these 8 deer had been
injected with GonaCon, and 6 of the 7 vaccinates had not
lactated during 2006 or 2007. (Two of these 7 deer had
received booster injections after summer 2006.) Ovaries of all
but one control deer were normal in size and contained small
follicles. Uterine size was within normal limits at necropsy in
all 16 examined GonaCon-treated adult females and in 9 of
10 examined control adult females.
Fawns (Females, 8 Months Old)
Of the 4 female fawns treated in February 2006, 1 left the
study site soon after vaccination and did not return. None of
the other 3 lactated as a yearling in 2006. Two did not lactate
as 2-year-olds in 2007; only 1 of these 2 deer (no. 76) was
necropsied in 2007 and it had small, inactive ovaries, an
enlarged uterus, and an anti-GnRH antibody titer of
1:128,000. The third deer (no. 78) lactated in 2007 and
had normal ovaries with small follicles, a small, inactive
uterus, and an antibody titer of 1:64,000.
Fawns (Females and Males, 3–4 Months Old)
Of the 8 female fawns treated in September–October 2006, 2
died of unknown causes before summer 2007. The remaining
6 females did not lactate as yearlings during summer 2007.
Five of these 6 females were collected in October 2007, when
they had anti-GnRH antibody titers ranging from 0 to
1:64,000. Necropsies of 4 of these deer revealed that ovaries
were small and/or inactive at necropsy in 2 deer, and ovaries
contained small follicles in 2 other deer. Two of these 4 deer
had small, inactive uteri (one had small ovaries and one had
normal ovaries with small follicles).
Seven of the 8 males treated as 3–4-month-old fawns
survived to the end of the study and were collected and
necropsied in October 2007. Testicular circumferences and
serum testosterone concentrations did not differ between
these males and control yearling males (circumferences:
t5 ¼ 1.75, P ¼ 0.070; testosterone: t7 ¼ 0.01, P ¼ 0.494),
or between these males and GonaCon-treated adult males
(circumferences: t7 ¼ 1.01, P ¼ 0.172; testosterone:
t5 ¼ 1.70, P ¼ 0.073).
Adult Males
Of 10 yearling and adult males treated duringMarch 2007, 2
died of unknown causes and 2 left the study site before
October 2007. One of the deer that left the site was observed
with large, normal-appearing antlers during late June 2007.
Four of the 6 males that remained on site had normal,
hardened antlers, and testes of normal size (16.0–19.5 cm
in circumference). In contrast, 2 others had antlers that were
still in velvet and smaller testes (2-sample t-test,
t3 ¼ 10.55, P < 0.001; testicular circumferences: 9.0 cm
and 9.5 cm). Overall, however, mean testicular circumfer-
ences did not differ (t5 ¼ 1.43, P ¼ 0.102) between males
treated as adults inMarch 2007 and a group of control adults.
Mean serum testosterone concentrations also did not differ
(t9 ¼ 0.13, P ¼ 0.449) between these 2 groups. Anti-
GnRH antibody titers were consistently low (1:8,000) in
males that had hardened antlers, normal testes, and moderate
testosterone levels, and they were consistently high
(1:32,000) in males that had antlers retaining velvet, small
testes, and relatively low testosterone levels.
Control Males
Thirteen previously untreated males were collected for nec-
ropsy during October 2007 for comparison (see above) with
GonaCon-treated males. Nine were adults with antlers nor-
mal in appearance and scrotal circumferences ranging from
15.5 cm to 20.0 cm. The other 4 males were yearlings with
normal spiked (n ¼ 3) or button (n ¼ 1) antlers. All antlers
lacked velvet and had hardened. Testicular circumferences in
control yearlings ranged from 13.5 cm to 17.0 cm and did
not differ (t3 ¼ 1.42, P ¼ 0.126) from those of control
adults. Serum testosterone concentrations were lower in
control yearlings than adults (t7 ¼ 2.55, P ¼ 0.018).
Anti-GnRH antibody titers were not measured, but were
assumed to be 0 in these noninjected males.
DISCUSSION
Induced Infertility in Female Deer
GonaCon Immunocontraceptive Vaccine induced temporary
infertility in a large proportion of treated adult female white-
tailed deer. The strength and duration of immune responses
to immunocontraceptive treatment varied among treated
individuals in this study and in previous studies (Miller
et al. 2008a; Gionfriddo et al. 2009). In the current study,
67% of GonaCon-treated adult female white-tailed deer
were infertile 1 year after vaccination, and 43% were infertile
after 2 years. In a similar field study in Maryland, 88% of
GonaCon-treated white-tailed females were infertile after
1 year, and 47% were infertile after 2 years (Gionfriddo et al.
2009). Captive adult female white-tailed deer (n ¼ 5)
treated with GonaCon at Pennsylvania State University
remained infertile for 2 years, and 4 of 5 deer were infertile
5 years after treatment (Miller et al. 2008a). Six of 10 captive
adult female black-tailed deer (Odocoileus hemionus hemionus)
in Washington State, USA, were infertile for 3 years after
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each received an injection of GonaCon vaccine (Perry et al.
2008).
Treatment of young (3–4-month-old) female fawns in our
study did not induce a strong, sustained immune response
required for contraception, a finding supported by Miller
et al. (2008b). This result suggests that the immune
systems of fawns may be insufficiently mature for immuno-
contraception, and that operational treatment of deer
with GonaCon vaccine should focus on adult females.
Nonetheless, experimental treatment of fawns to determine
contraceptive efficacy is important because future wildlife
contraceptive agents could be delivered orally, and treated
bait may be consumed by deer of all ages.
The level of circulating anti-GnRH antibodies is a good
indicator of the fertility status of an animal treated with an
immunocontraceptive agent (McShea et al. 1997). Other
than infertility, no side effects are associated with the pres-
ence of antibodies against GnRH (Delves 2002). In most
treated animals, fertility is naturally regained after a decline
in antibody titers (Keeling and Crighton 1984).
The immune response must reach and maintain a threshold
level for contraception to occur (Adams and Adams 1990,
Zeng et al. 2002). In white-tailed deer, infertility is normally
associated with anti-GnRH antibody titers 1:64,000
(Miller et al. 2000, 2008a; Gionfriddo et al. 2009). In the
current study, 27 months after vaccination, titers were
1:64,000 in 4 (29%) of 14 nonboosted GonaCon-treated
adult females, all of which were infertile in 2006 and
2007. Of the 5 examined females that were vaccinated in
September–October 2006 as 3–4-month-old fawns, 1 (20%)
had a titer1:64,000. Although these 5 deer were vaccinated
too late in the 2006–2007 reproductive cycle to affect repro-
duction that year, they were likely too young to breed until
(at least) autumn 2007. Both of the females that had been
vaccinated at 8 months of age and remained alive on the
study site had titers 1:64,000, although one of them was
pregnant in 2007.
Severe overbrowsing was evident throughout the study area
when the study began. Most deer captured in July 2005 were
noticeably thin, with body masses estimated at 32–57 kg.
Healthy adult female white-tailed deer in the northeastern
United States generally weigh 41–96 kg (Whitaker and
Hamilton 1998). Fat reserves in study deer at necropsy in
2007 were generally meager (Gionfriddo et al. 2011). The
relationship between nutrition and immune response has
long been recognized (Homsy et al. 1986, Chandra and
Amorin 1992), and it is possible that stronger immune
responses (and greater contraceptive efficacy) may have
been achieved if study deer had been in better physical
condition. As a practical matter, however, most overabun-
dant deer populations that would be candidates for treatment
with contraceptive agents would likely have experienced
suboptimal nutrition.
Small and inactive ovaries and uteri, as observed in many of
the GonaCon-treated females in this study, are commonly
associated with GnRH immunocontraception and are indi-
cators of successful contraception. GonaCon induces the
production of anti-GnRH antibodies that bind to endoge-
nous GnRH and prevent the release of luteinizing hormone
(LH) and follicle-stimulating hormone (FSH) from the
anterior pituitary gland. In the absence of LH and FSH,
the gonads remain quiescent, production of sex hormones is
sharply reduced, and the animal remains in a nonreproduc-
tive state.
The administration of booster vaccine injections to several
of our adult female study deer provided an opportunity to
evaluate the effect of such injections on contraceptive effica-
cy. For example, females numbered 17 and 29 were each
given a 1.0-mL booster injection of GonaCon in October
2006 after lactating during summer 2006. Neither female
lactated in 2007; both females had very high anti-GnRH
antibody titers (1:128,000) when collected in October 2007,
suggesting that the booster injections had stimulated strong
immune responses. Deer number 28 followed a similar pat-
tern. After her pregnancy in summer 2006, she was boosted
in October and then did not lactate in 2007. Unfortunately
her carcass was too badly decomposed when it was found in
September 2007 to permit blood collection or necropsy
examination. In contrast to these examples, a booster injec-
tion did not seem to be effective in deer number 5. She
lactated in summer 2006, was boosted in October 2006, and
lactated again in 2007. Her antibody titer was 1:32,000 in
October 2007. Booster vaccine injections seem to increase or
extend contraceptive efficacy in some, but not all, cases.
Responses of Male Deer to Vaccination
Although mean values for testicular circumferences and
serum testosterone concentrations did not differ between
GonaCon-treated and control males, vaccination with
GonaCon affected reproductive parameters in some adult
males (no. 81 and 82), which, 12 months after vaccination,
had small testes, negligible testosterone concentrations, and
antlers that retained velvet into October. In contrast, treated
adult males 87, 88, and 90 had ‘‘normal’’ values for these
parameters when compared with control adult males. Anti-
GnRH antibody titers in males treated with GonaCon as 3–
4-month-old fawns were similar to those of same-aged
females and support the hypothesis that immunocontracep-
tion of young fawns may not be feasible.
In our study, deer were collected for necropsy in early
October when testosterone concentrations normally increase
as the rut approaches (Mirarchi et al. 1977). Treatment with
GonaCon vaccine typically reduces the production of testos-
terone and growth of testes (Killian et al. 2005), and pro-
duces males that resemble morphological castrates. Thus it
was not surprising that 2 treated deer had smaller testes and
lower testosterone concentrations than untreated deer.
Curtis et al. (2008) reported similar results for free-ranging
male white-tailed deer treated with GnRH vaccines. We
agree with Killian et al. (2005) and Curtis et al. (2008) that
male deer should not be treated with GnRH vaccines because
of potential social consequences for treated individuals.
MANAGEMENT IMPLICATIONS
Successful management of overabundant suburban deer pop-
ulations requires an initial reduction in numbers to a desired
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density, and then maintenance of that density (Merrill et al.
2006). Contraceptive efficacy rates demonstrated for
GonaCon vaccine in New Jersey support the contention
that the most efficient approach to managing overabundant
suburban deer populations may be to combine culling (for
initial population reduction) and contraception (for popula-
tion stabilization; Bomford 1990, Hobbs et al. 2000). Once
deer numbers have been reduced to a desired level, popula-
tion stability can be achieved by preventing about 60–80% of
the breeding females from reproducing each year (Garrott
1995, McCullough 1996). Such levels of infertility should be
achievable through rigorous application of GonaCon vac-
cine. Timely reduction of overabundant deer populations
using contraception alone, however, is not feasible at current
efficacy rates.
The need for safe, effective, practical, and humane wildlife
contraceptive agents to manage overabundant wildlife pop-
ulations in situations where traditional management meth-
ods cannot be applied will continue to drive the development
of contraceptive products. Immunocontraception of white-
tailed deer shows promise as a tool for stabilizing demo-
graphically closed populations, but improvements may be
needed if this technology is to be accepted and applied widely
in real-world settings by natural resource professionals.
Greater contraceptive efficacy (i.e., a higher proportion of
treated animals rendered infertile and a longer duration of
contraceptive effect) is a goal of ongoing research.
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